PDB26 COST-EFFECTIVENESS OF ROSIGLITAZONE FOR TREATMENT OF TYPE 2 DIABETES IN PORTUGAL USING DIFFERENT METHODS TO MODEL CLINICAL EFFECTS
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63296-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)63296-2/fulltext
Title :
PDB26 COST-EFFECTIVENESS OF ROSIGLITAZONE FOR TREATMENT OF TYPE 2 DIABETES IN PORTUGAL USING DIFFERENT METHODS TO MODEL CLINICAL EFFECTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63296-2&doi=10.1016/S1098-3015(10)63296-2
First page :
Section Title :
Open access? :
No
Section Order :
147